Figure 2.
The occurrence rate of newly-onset peripheral arterial occlusive disease (PAOD) progressively increased from CHA2DS2-VASc score 0 to 9 (A) and from study group 1 to group 6 (B).
The occurrence rate of newly-onset peripheral arterial occlusive disease (PAOD) progressively increased from CHA2DS2-VASc score 0 to 9 (A) and from study group 1 to group 6 (B).